Ignite Creation Date:
2024-05-06 @ 7:25 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06001658
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2023-08-08
Brief Title:
Perioperative Gemcitabine Cisplatin and Pembrolizumab in Potentially Resectable Biliary Tract Cancers
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-06
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-08
First Submit QC Date:
August 16 2023
Study First Post Date:
2023-08-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-24
Last Update Post Date:
2024-06-26
Last Update Post Date Type:
ACTUAL